Alzheimer's-associated upregulation of mitochondria-associated ER membranes after traumatic brain injury

Autor: Rishi R. Agrawal, Delfina Larrea, Yimeng Xu, Lingyan Shi, Hylde Zirpoli, Leslie G. Cummins, Valentina Emmanuele, Donghui Song, Taekyung D. Yun, Frank P. Macaluso, Wei Min, Steven G. Kernie, Richard J. Deckelbaum, Estela Area-Gomez
Přispěvatelé: Consejo Superior de Investigaciones Científicas (España), National Institutes of Health (US), Department of Defense (US), Agrawal, Rishi R., Larrea, Delfina, Zirpoli, Hylde, Cummins, Leslie G., Area-Gomez, Estela
Rok vydání: 2020
Předmět:
Traumatic
Aging
Hippocampus
Neurodegenerative
Mitochondrion
Endoplasmic Reticulum
Alzheimer's Disease
Mice
Amyloid beta-Protein Precursor
Contact sites
Amyloid precursor protein
2.1 Biological and endogenous factors
Brain injury
Aetiology
Microglia
biology
Pharmacology and Pharmaceutical Sciences
General Medicine
Alzheimer's
Lipids
Mitochondria
Up-Regulation
medicine.anatomical_structure
Neurological
Alzheimer's disease
medicine.medical_specialty
Physical Injury - Accidents and Adverse Effects
Traumatic brain injury
1.1 Normal biological development and functioning
Traumatic Brain Injury (TBI)
Cellular and Molecular Neuroscience
Downregulation and upregulation
Alzheimer Disease
Underpinning research
Internal medicine
Acquired Cognitive Impairment
medicine
Animals
Neurodegeneration
Traumatic Head and Spine Injury
Neurology & Neurosurgery
business.industry
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Lipid metabolism
Cell Biology
medicine.disease
Brain Disorders
Endocrinology
Brain Injuries
biology.protein
Dementia
Biochemistry and Cell Biology
business
Alzheimer’s
Zdroj: Cellular and molecular neurobiology, vol 43, iss 5
DOI: 10.1101/2020.11.13.381756
Popis: 23 p.-5 fig.-3 tab.-1 graph. abst.
Traumatic brain injury (TBI) can lead to neurodegenerative diseases such as Alzheimer’s disease (AD) through mechanisms that remain incompletely characterized. Similar to AD, TBI models present with cellular metabolic alterations and modulated cleavage of amyloid precursor protein (APP). Specifically, AD and TBI tissues display increases in amyloid-β as well as its precursor, the APP C-terminal fragment of 99 a.a. (C99). Our recent data in cell models of AD indicate that C99, due to its affinity for cholesterol, induces the formation of transient lipid raft domains in the ER known as mitochondria-associated endoplasmic reticulum (ER) membranes (“MAM” domains). The formation of these domains recruits and activates specific lipid metabolic enzymes that regulate cellular cholesterol trafficking and sphingolipid turnover. Increased C99 levels in AD cell models promote MAM formation and significantly modulate cellular lipid homeostasis. Here, these phenotypes were recapitulated in the controlled cortical impact (CCI) model of TBI in adult mice. Specifically, the injured cortex and hippocampus displayed significant increases in C99 and MAM activity, as measured by phospholipid synthesis, sphingomyelinase activity and cholesterol turnover. In addition, our cell type-specific lipidomics analyses revealed significant changes in microglial lipid composition that are consistent with the observed alterations in MAM-resident enzymes. Altogether, we propose that alterations in the regulation of MAM and relevant lipid metabolic pathways could contribute to the epidemiological connection between TBI and AD.
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by the U.S. National Institutes of Health (T32-DK007647 to RRA; R21NS125395 to LS; S10-OD016214 and P30-CA013330 to FPM; R01-EB029523 to WM; R01-NS095803 to SGK; R01-NS088197 to RJD; R01-AG056387 to EA-G) and the U.S. Department of Defense (National Defense Science and Engineering Graduate Fellowship, FA9550-11-C-0028, to RRA).
Databáze: OpenAIRE